Skip to main content
. 2021 Nov 15;398(10317):2186–2192. doi: 10.1016/S0140-6736(21)02507-1

Table 1.

COVID-19 vaccines FDA-approved for emergency use in the USA as of June 14, 2021

Initial FDA authorisation date Vaccine type Number of doses for full immunisation Age for which use was approved
Pfizer-BioNTech* Dec 11, 2020 mRNA Two 12 years and older
Moderna Dec 18, 2020 mRNA Two 18 years and older
Janssen (Johnson & Johnson) Feb 27, 2021 Viral vector (adenovirus type 26) One 18 years and older

FDA=US Food and Drug Administration.

*

The Pfizer-BioNTech vaccine received full FDA approval on Aug 23, 2021.